Adrian Looney, Senior Vice President & Chief Intellectual Property Officer at Vertex Pharmaceuticals

Adrian Looney

Senior Vice President & Chief Intellectual Property Officer at Vertex Pharmaceuticals | New York, New York, United States

Profile last verified June 2026
Pharmaceuticals Verified Profile New York, New York, United States New York Law School
Verified

Work Email

***@vrtx.com

Last verified July 2026

Phone Number

732*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Adrian Looney Socials
Adrian Looney Work Experience

Senior Vice President & Chief Intellectual Property Officer at Vertex Pharmaceuticals in February 2024 - Present

Vice President, Chief Intellectual Property Officer at Vertex Pharmaceuticals in January 2022 - February 2024

Vice President & Assistant General Counsel at Pfizer in November 2016 - December 2021

See more See less

Assistant General Counsel at Pfizer in April 2012 - October 2016

Senior IP Attorney at Pfizer in January 2004 - March 2012

Corporate Counsel at Pfizer in January 2000 - December 2003

law clerk and associate at Fitzpatrick, Cella, Harper & Scinto in January 1996 - January 1999

Scientific Advisor at Cooper & Dunham LLP in January 1993 - January 1996

Adrian Looney Education

New York Law School, JD, January 1994 to January 1998

Columbia University in the City of New York, M.A., M.Phil., Ph.D., January 1988 to January 1993

University College Cork, Bachelor’s Degree, January 1984 to January 1988

Adrian Looney Skills
Intellectual Property Trade Secrets Lifesciences Patents Patent Litigation Biotechnology Patent Prosecution Licensing Technology Transfer Pharmaceutical Industry Patentability Due Diligence Regulatory Affairs Biopharmaceuticals Trademarks Corporate Law
About Adrian Looney’s Current Company
Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

Discover more about Vertex Pharmaceuticals
Adrian Looney’s Colleagues
Kristie Kapinas

Kristie Kapinas

San Diego Metropolitan Area

CF Medical Science Liaison at Vertex Pharmaceuticals

Senior Medical Science Liaison, Cystic Fibrosis at Vertex Pharmaceuticals
(August 2021 – Present)

Marsha Wibowo

Marsha Wibowo

Greater Boston

Computational Genomics Research Scientist at Vertex Pharmaceuticals

Computational Genomics Research Scientist at Vertex Pharmaceuticals
(April 2022 – Present)

Ashley Mahoney

Ashley Mahoney

Cohasset, Massachusetts, United States

Director External Communications, Vertex Pharmaceuticals

Director External Communications at Vertex Pharmaceuticals
(November 2021 – Present)

Gina Lacorcia

Gina Lacorcia

Framingham, Massachusetts, United States

Vice President, Chief of Staff to the CEO & Head of the Disease Strategy Team Program Office

Vice President, Chief of Staff to the CEO & Head of the Disease Strategy Team Program Office at Vertex Pharmaceuticals
(February 2023 – Present)

Kristen Clare

Kristen Clare

Boston, Massachusetts, United States

Regulatory Affairs Professional

Manager, Regional Regulatory Strategist (US) at Shire
(August 2015 – July 2026)

Rubben Torella

Rubben Torella

Greater Boston

Senior Principal Research Scientist at Vertex

Senior Principal Research Scientist at Vertex Pharmaceuticals
(April 2023 – Present)

Search similar profiles
Frequently asked questions about Adrian Looney

What is Adrian Looney email address?

Email Adrian Looney at [email protected]. This email is the most updated Adrian Looney's email found in 2026.

What is Adrian Looney phone number?

Adrian Looney phone number is 7329867256.

How to contact Adrian Looney?

To contact Adrian Looney send an email to [email protected]. If you want to call Adrian Looney try calling on 7329867256.

What company does Adrian Looney work for?

Adrian Looney works for Vertex Pharmaceuticals.

What is Adrian Looney's role at Vertex Pharmaceuticals?

Adrian Looney is Senior Vice President & Chief Intellectual Property Officer

What industry does Adrian Looney work in?

Adrian Looney works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free